Original Research
Published on 18 Mar 2022
A Combined Pharmacometrics Analysis of Biomarker Distribution Under Treatment With Standard- or Low-Dose Rivaroxaban in Real-World Chinese Patients With Nonvalvular Atrial Fibrillation
in Drug Metabolism and Transport
- 2,619 views
- 4 citations